Literature DB >> 24906497

Sensitisation of TRPV4 by PAR2 is independent of intracellular calcium signalling and can be mediated by the biased agonist neutrophil elastase.

Silvia Sostegni1, Alexei Diakov, Peter McIntyre, Nigel Bunnett, Christoph Korbmacher, Silke Haerteis.   

Abstract

Proteolytic activation of protease-activated receptor 2 (PAR2) may represent a major mechanism of regulating the transient receptor potential vanilloid 4 (TRPV4) non-selective cation channel in pathophysiological conditions associated with protease activation (e.g. during inflammation). To provide electrophysiological evidence for PAR2-mediated TRPV4 regulation, we characterised the properties of human TRPV4 heterologously expressed in Xenopus laevis oocytes in the presence and absence of co-expressed human PAR2. In outside-out patches from TRPV4 expressing oocytes, we detected single-channel activity typical for TRPV4 with a single-channel conductance of about 100 pS for outward and 55 pS for inward currents. The synthetic TRPV4 activator GSK1016790A stimulated TRPV4 mainly by converting previously silent channels into active channels with an open probability of nearly one. In oocytes co-expressing TRPV4 and PAR2, PAR2 activation by trypsin or by specific PAR2 agonist SLIGRL-NH2 potentiated the GSK1016790A-stimulated TRPV4 whole-cell currents several fold, indicative of channel sensitisation. Pre-incubation of oocytes with the calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA)-AM did not reduce the stimulatory effect of PAR2 activation on TRPV4, which indicates that the effect is independent of intracellular calcium signalling. Neutrophil elastase, a biased agonist of PAR2 that does not induce intracellular calcium signalling, also caused a PAR2-dependent sensitisation of TRPV4. The Rho-kinase inhibitor Y27362 abolished elastase-stimulated sensitisation of TRPV4, which indicates that Rho-kinase signalling plays a critical role in PAR2-mediated TRPV4 sensitisation by the biased agonist neutrophil elastase. During acute inflammation, neutrophil elastase may sensitise TRPV4 by a mechanism involving biased agonism of PAR2 and activation of Rho-kinase.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24906497     DOI: 10.1007/s00424-014-1539-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  78 in total

1.  Optical recording reveals novel properties of GSK1016790A-induced vanilloid transient receptor potential channel TRPV4 activity in primary human endothelial cells.

Authors:  Michelle N Sullivan; Michael Francis; Natalie L Pitts; Mark S Taylor; Scott Earley
Journal:  Mol Pharmacol       Date:  2012-06-11       Impact factor: 4.436

Review 2.  TRPV4: new therapeutic target for inflammatory bowel diseases.

Authors:  Nathalie Vergnolle
Journal:  Biochem Pharmacol       Date:  2014-01-16       Impact factor: 5.858

Review 3.  TRP channels: a TR(I)P through a world of multifunctional cation channels.

Authors:  Bernd Nilius; Thomas Voets
Journal:  Pflugers Arch       Date:  2005-07-13       Impact factor: 3.657

4.  Proteinase-activated receptors, targets for kallikrein signaling.

Authors:  Katerina Oikonomopoulou; Kristina K Hansen; Mahmoud Saifeddine; Illa Tea; Michael Blaber; Sachiko I Blaber; Isobel Scarisbrick; Patricia Andrade-Gordon; Graeme S Cottrell; Nigel W Bunnett; Eleftherios P Diamandis; Morley D Hollenberg
Journal:  J Biol Chem       Date:  2006-08-02       Impact factor: 5.157

5.  Molecular cloning of a potential proteinase activated receptor.

Authors:  S Nystedt; K Emilsson; C Wahlestedt; J Sundelin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

6.  A transient calcium-dependent chloride current in the immature Xenopus oocyte.

Authors:  M E Barish
Journal:  J Physiol       Date:  1983-09       Impact factor: 5.182

7.  Antagonism of protease-activated receptor 2 protects against experimental colitis.

Authors:  Rink-Jan Lohman; Adam J Cotterell; Jacky Suen; Ligong Liu; Anh T Do; David A Vesey; David P Fairlie
Journal:  J Pharmacol Exp Ther       Date:  2011-10-25       Impact factor: 4.030

8.  Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms.

Authors:  Nicolas Cenac; Christophe Altier; Kevin Chapman; Wolfgang Liedtke; Gerald Zamponi; Nathalie Vergnolle
Journal:  Gastroenterology       Date:  2008-05-10       Impact factor: 22.682

9.  Identification and characterization of novel TRPV4 modulators.

Authors:  Fabien Vincent; Alejandra Acevedo; Margaret T Nguyen; Michelle Dourado; Jeff DeFalco; Amy Gustafson; Peter Spiro; Daniel E Emerling; Michael G Kelly; Matthew A J Duncton
Journal:  Biochem Biophys Res Commun       Date:  2009-09-06       Impact factor: 3.575

10.  Protease modulation of the activity of the epithelial sodium channel expressed in Xenopus oocytes.

Authors:  A Chraïbi; V Vallet; D Firsov; S K Hess; J D Horisberger
Journal:  J Gen Physiol       Date:  1998-01       Impact factor: 4.086

View more
  9 in total

1.  Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.

Authors:  Peishen Zhao; TinaMarie Lieu; Nicholas Barlow; Silvia Sostegni; Silke Haerteis; Christoph Korbmacher; Wolfgang Liedtke; Nestor N Jimenez-Vargas; Stephen J Vanner; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

2.  Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2.

Authors:  Milind M Muley; Allison R Reid; Bálint Botz; Kata Bölcskei; Zsuzsanna Helyes; Jason J McDougall
Journal:  Br J Pharmacol       Date:  2015-07-31       Impact factor: 8.739

Review 3.  Visceral pain from colon and rectum: the mechanotransduction and biomechanics.

Authors:  Bin Feng; Tiantian Guo
Journal:  J Neural Transm (Vienna)       Date:  2019-10-09       Impact factor: 3.575

Review 4.  TRPV4 as a therapeutic target for joint diseases.

Authors:  Amy L McNulty; Holly A Leddy; Wolfgang Liedtke; Farshid Guilak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-12-18       Impact factor: 3.000

Review 5.  Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS.

Authors:  Lisse Decraecker; Guy Boeckxstaens; Alexandre Denadai-Souza
Journal:  Front Physiol       Date:  2022-05-19       Impact factor: 4.755

Review 6.  Proteinases and their receptors in inflammatory arthritis: an overview.

Authors:  Katerina Oikonomopoulou; Eleftherios P Diamandis; Morley D Hollenberg; Vinod Chandran
Journal:  Nat Rev Rheumatol       Date:  2018-02-08       Impact factor: 20.543

Review 7.  Transient receptor potential cation channel subfamily V and breast cancer.

Authors:  Choon Leng So; Michael J G Milevskiy; Gregory R Monteith
Journal:  Lab Invest       Date:  2019-12-10       Impact factor: 5.662

8.  Calcium Increase and Substance P Release Induced by the Neurotoxin Brevetoxin-1 in Sensory Neurons: Involvement of PAR2 Activation through Both Cathepsin S and Canonical Signaling.

Authors:  Ophélie Pierre; Maxime Fouchard; Paul Buscaglia; Nelig Le Goux; Raphaël Leschiera; Olivier Mignen; Joachim W Fluhr; Laurent Misery; Raphaële Le Garrec
Journal:  Cells       Date:  2020-12-17       Impact factor: 6.600

9.  Cathepsin S Evokes PAR2-Dependent Pain in Oral Squamous Cell Carcinoma Patients and Preclinical Mouse Models.

Authors:  Nguyen Huu Tu; Kenji Inoue; Elyssa Chen; Bethany M Anderson; Caroline M Sawicki; Nicole N Scheff; Hung D Tran; Dong H Kim; Robel G Alemu; Lei Yang; John C Dolan; Cheng Z Liu; Malvin N Janal; Rocco Latorre; Dane D Jensen; Nigel W Bunnett; Laura E Edgington-Mitchell; Brian L Schmidt
Journal:  Cancers (Basel)       Date:  2021-09-19       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.